Clinical applications of genetic/genomic testing are potentially important but, as others have observed, “the current knowledge base . . . to turn the promise of genomic medicine into reality is severely limited.”
“The report was developed by a multidisciplinary group, including Hayes’ Senior Medical Research Analyst Margaret Piper, PhD, MPH.”
In March 2017, the National Academies of Sciences, Engineering, and Medicine released a study report titled “An Evidence Framework for Genetic Testing.” The report was developed by a multidisciplinary group, including Hayes’ Senior Medical Research Analyst Margaret Piper, PhD, MPH.
Central to the report was the recommendation of a framework for decision making regarding the use of genetic tests in clinical care. The report outlines 7 evaluation steps, including:
- The definition of the genetic test clinical scenario
- Conducting evidence reviews
- Completing a structured and transparent decision process with routine updating and review of new evidence
The recommended evaluation steps bear significant similarities to the Hayes Genetic Test Evaluation (GTE) evidence assessment process, with only a few differences in report options, as well as in the recognition that policy decisions may incorporate other factors in addition to evidence.
As a Hayes client and subscriber to the GTE program, you should feel reassured to see the methods used by the Hayes Genetics team reinforced in this report. You can trust that you are receiving unbiased evidence assessments performed with scientific rigor by experts in their field.
If you are not yet utilizing the Hayes evidence solution, there is no better time to discover how we have both the time and expertise to help you navigate concepts of genetic testing such as analytical validity, clinical validity, and clinical utility. Read our FREE eBook, 5 Questions to Ask Before Entering the Maze of Genetic Testing; then contact us to schedule a demo.